We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Health Canada has finalized regulations that knock the U.S. and Switzerland off its price comparator list and tighten disclosure requirements. Read More
A group of senators hit out at Novartis subsidiary AveXis on Friday for using falsified data in the approval process of its gene therapy product Zolgensma (onasemnogene abeparvovec-xioi). Read More
The agency will not award any vouchers after Sept. 30, 2020, unless the application is for a drug that was designated as a drug for a rare pediatric disease. Read More
The FDA has okayed the use of a single trial to prove efficacy of any drug developed to treat Fabry Disease, according to a draft guidance the agency issued last week. Read More